Transaction in Own Shares

By

Regulatory News | 27 Sep, 2024

Updated : 07:02

RNS Number : 8888F
Centrica PLC
27 September 2024
 

Transactions in own shares

 

Centrica plc

27 September 2024

 

Centrica plc announces that it purchased on 26 September 2024 (through Goldman Sachs International) 253,378 Centrica plc ordinary shares of 6 14/81 pence each at a price of 117.1100 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the Company's buyback programme announced on 8 August 2024 and in accordance with the non-discretionary share repurchase agreement entered into with Goldman Sachs International.

 

Since 8 August 2024, Centrica has purchased 20,529,474 ordinary shares at a cost (excluding dealing and associated costs) of £25,391,601.90.

 

Following the above purchase, Centrica plc holds 454,859,032 ordinary shares in treasury, and has 5,203,248,182 ordinary shares in issue (excluding treasury shares).

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation)(as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by Goldman Sachs International is set out below.

 

Transaction details: Centrica plc ordinary shares of 6 14/81 pence each

 

Issuer name:

Centrica plc

ISIN:

GB00B033F229

Intermediary name:

Goldman Sachs International

Intermediary Code:

GSILGB2XXXX

Currency:

GBP

 

Aggregated information

Date of purchase:

26 September 2024

Number of ordinary shares purchased:

253,378

Highest price paid:

118.4500p

Lowest price paid:

116.1500p

Volume weighted average price paid per share:

117.1100p

 

Disaggregated information

 

The table attached contains detailed information of the individual trades made by Goldman Sachs International, as part of the buyback programme.

 

Click on, or paste the following link into your web browser, to view the associated PDF document.


http://www.rns-pdf.londonstockexchange.com/rns/8888F_1-2024-9-26.pdf

 

END

 

Enquiries:

Investors and Analysts

T: 01753 494900

E: ir@centrica.com

 

 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDZGZLVVFGDZM

Last news